nodes	percent_of_prediction	percent_of_DWPC	metapath
Anagrelide—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.00195	0.00195	CcSEcCtD
Anagrelide—Depression—Methotrexate—ankylosing spondylitis	0.00195	0.00195	CcSEcCtD
Anagrelide—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.00194	0.00194	CcSEcCtD
Anagrelide—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.00194	0.00194	CcSEcCtD
Anagrelide—Discomfort—Triamcinolone—ankylosing spondylitis	0.00194	0.00194	CcSEcCtD
Anagrelide—Discomfort—Methylprednisolone—ankylosing spondylitis	0.00194	0.00194	CcSEcCtD
Anagrelide—Dry mouth—Triamcinolone—ankylosing spondylitis	0.00192	0.00192	CcSEcCtD
Anagrelide—Renal failure—Methotrexate—ankylosing spondylitis	0.00192	0.00192	CcSEcCtD
Anagrelide—Conjunctivitis—Methotrexate—ankylosing spondylitis	0.0019	0.0019	CcSEcCtD
Anagrelide—Confusional state—Methylprednisolone—ankylosing spondylitis	0.0019	0.0019	CcSEcCtD
Anagrelide—Malaise—Dexamethasone—ankylosing spondylitis	0.00189	0.00189	CcSEcCtD
Anagrelide—Malaise—Betamethasone—ankylosing spondylitis	0.00189	0.00189	CcSEcCtD
Anagrelide—Oedema—Triamcinolone—ankylosing spondylitis	0.00188	0.00188	CcSEcCtD
Anagrelide—Syncope—Betamethasone—ankylosing spondylitis	0.00188	0.00188	CcSEcCtD
Anagrelide—Syncope—Dexamethasone—ankylosing spondylitis	0.00188	0.00188	CcSEcCtD
Anagrelide—Arrhythmia—Prednisone—ankylosing spondylitis	0.00187	0.00187	CcSEcCtD
Anagrelide—Infection—Triamcinolone—ankylosing spondylitis	0.00187	0.00187	CcSEcCtD
Anagrelide—Sweating—Methotrexate—ankylosing spondylitis	0.00187	0.00187	CcSEcCtD
Anagrelide—Infection—Methylprednisolone—ankylosing spondylitis	0.00187	0.00187	CcSEcCtD
Anagrelide—Haematuria—Methotrexate—ankylosing spondylitis	0.00186	0.00186	CcSEcCtD
Anagrelide—Shock—Triamcinolone—ankylosing spondylitis	0.00185	0.00185	CcSEcCtD
Anagrelide—Insomnia—Prednisolone—ankylosing spondylitis	0.00185	0.00185	CcSEcCtD
Anagrelide—Alopecia—Prednisone—ankylosing spondylitis	0.00185	0.00185	CcSEcCtD
Anagrelide—Shock—Methylprednisolone—ankylosing spondylitis	0.00185	0.00185	CcSEcCtD
Anagrelide—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.00185	0.00185	CcSEcCtD
Anagrelide—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.00184	0.00184	CcSEcCtD
Anagrelide—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.00184	0.00184	CcSEcCtD
Anagrelide—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.00184	0.00184	CcSEcCtD
Anagrelide—Epistaxis—Methotrexate—ankylosing spondylitis	0.00184	0.00184	CcSEcCtD
Anagrelide—Paraesthesia—Prednisolone—ankylosing spondylitis	0.00184	0.00184	CcSEcCtD
Anagrelide—Tachycardia—Triamcinolone—ankylosing spondylitis	0.00184	0.00184	CcSEcCtD
Anagrelide—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.00184	0.00184	CcSEcCtD
Anagrelide—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.00183	0.00183	CcSEcCtD
Anagrelide—Malnutrition—Prednisone—ankylosing spondylitis	0.00182	0.00182	CcSEcCtD
Anagrelide—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.00182	0.00182	CcSEcCtD
Anagrelide—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.00182	0.00182	CcSEcCtD
Anagrelide—Convulsion—Dexamethasone—ankylosing spondylitis	0.00182	0.00182	CcSEcCtD
Anagrelide—Convulsion—Betamethasone—ankylosing spondylitis	0.00182	0.00182	CcSEcCtD
Anagrelide—Hypertension—Dexamethasone—ankylosing spondylitis	0.00181	0.00181	CcSEcCtD
Anagrelide—Hypertension—Betamethasone—ankylosing spondylitis	0.00181	0.00181	CcSEcCtD
Anagrelide—Myalgia—Dexamethasone—ankylosing spondylitis	0.00178	0.00178	CcSEcCtD
Anagrelide—Myalgia—Betamethasone—ankylosing spondylitis	0.00178	0.00178	CcSEcCtD
Anagrelide—Discomfort—Dexamethasone—ankylosing spondylitis	0.00176	0.00176	CcSEcCtD
Anagrelide—Discomfort—Betamethasone—ankylosing spondylitis	0.00176	0.00176	CcSEcCtD
Anagrelide—Haemoglobin—Methotrexate—ankylosing spondylitis	0.00176	0.00176	CcSEcCtD
Anagrelide—Hypotension—Methylprednisolone—ankylosing spondylitis	0.00176	0.00176	CcSEcCtD
Anagrelide—Pain—Prednisolone—ankylosing spondylitis	0.00175	0.00175	CcSEcCtD
Anagrelide—Haemorrhage—Methotrexate—ankylosing spondylitis	0.00175	0.00175	CcSEcCtD
Anagrelide—Hepatitis—Methotrexate—ankylosing spondylitis	0.00175	0.00175	CcSEcCtD
Anagrelide—Pharyngitis—Methotrexate—ankylosing spondylitis	0.00174	0.00174	CcSEcCtD
Anagrelide—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.00173	0.00173	CcSEcCtD
Anagrelide—Vision blurred—Prednisone—ankylosing spondylitis	0.00172	0.00172	CcSEcCtD
Anagrelide—Urethral disorder—Methotrexate—ankylosing spondylitis	0.00172	0.00172	CcSEcCtD
Anagrelide—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.00172	0.00172	CcSEcCtD
Anagrelide—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.00171	0.00171	CcSEcCtD
Anagrelide—Oedema—Betamethasone—ankylosing spondylitis	0.00171	0.00171	CcSEcCtD
Anagrelide—Oedema—Dexamethasone—ankylosing spondylitis	0.00171	0.00171	CcSEcCtD
Anagrelide—Insomnia—Triamcinolone—ankylosing spondylitis	0.0017	0.0017	CcSEcCtD
Anagrelide—Insomnia—Methylprednisolone—ankylosing spondylitis	0.0017	0.0017	CcSEcCtD
Anagrelide—Infection—Betamethasone—ankylosing spondylitis	0.0017	0.0017	CcSEcCtD
Anagrelide—Infection—Dexamethasone—ankylosing spondylitis	0.0017	0.0017	CcSEcCtD
Anagrelide—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.00169	0.00169	CcSEcCtD
Anagrelide—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.00169	0.00169	CcSEcCtD
Anagrelide—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.00169	0.00169	CcSEcCtD
Anagrelide—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.00169	0.00169	CcSEcCtD
Anagrelide—Visual impairment—Methotrexate—ankylosing spondylitis	0.00169	0.00169	CcSEcCtD
Anagrelide—Anaemia—Prednisone—ankylosing spondylitis	0.00169	0.00169	CcSEcCtD
Anagrelide—Shock—Dexamethasone—ankylosing spondylitis	0.00168	0.00168	CcSEcCtD
Anagrelide—Shock—Betamethasone—ankylosing spondylitis	0.00168	0.00168	CcSEcCtD
Anagrelide—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.00168	0.00168	CcSEcCtD
Anagrelide—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.00168	0.00168	CcSEcCtD
Anagrelide—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.00168	0.00168	CcSEcCtD
Anagrelide—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.00167	0.00167	CcSEcCtD
Anagrelide—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.00167	0.00167	CcSEcCtD
Anagrelide—Tachycardia—Dexamethasone—ankylosing spondylitis	0.00167	0.00167	CcSEcCtD
Anagrelide—Tachycardia—Betamethasone—ankylosing spondylitis	0.00167	0.00167	CcSEcCtD
Anagrelide—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.00166	0.00166	CcSEcCtD
Anagrelide—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.00166	0.00166	CcSEcCtD
Anagrelide—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.00165	0.00165	CcSEcCtD
Anagrelide—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.00165	0.00165	CcSEcCtD
Anagrelide—Malaise—Prednisone—ankylosing spondylitis	0.00165	0.00165	CcSEcCtD
Anagrelide—Eye disorder—Methotrexate—ankylosing spondylitis	0.00164	0.00164	CcSEcCtD
Anagrelide—Syncope—Prednisone—ankylosing spondylitis	0.00164	0.00164	CcSEcCtD
Anagrelide—Tinnitus—Methotrexate—ankylosing spondylitis	0.00163	0.00163	CcSEcCtD
Anagrelide—Anorexia—Dexamethasone—ankylosing spondylitis	0.00163	0.00163	CcSEcCtD
Anagrelide—Anorexia—Betamethasone—ankylosing spondylitis	0.00163	0.00163	CcSEcCtD
Anagrelide—Urticaria—Prednisolone—ankylosing spondylitis	0.00163	0.00163	CcSEcCtD
Anagrelide—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.00163	0.00163	CcSEcCtD
Anagrelide—Fatigue—Triamcinolone—ankylosing spondylitis	0.00163	0.00163	CcSEcCtD
Anagrelide—Fatigue—Methylprednisolone—ankylosing spondylitis	0.00162	0.00162	CcSEcCtD
Anagrelide—Pain—Triamcinolone—ankylosing spondylitis	0.00161	0.00161	CcSEcCtD
Anagrelide—Loss of consciousness—Prednisone—ankylosing spondylitis	0.0016	0.0016	CcSEcCtD
Anagrelide—Hypotension—Betamethasone—ankylosing spondylitis	0.0016	0.0016	CcSEcCtD
Anagrelide—Hypotension—Dexamethasone—ankylosing spondylitis	0.0016	0.0016	CcSEcCtD
Anagrelide—Convulsion—Prednisone—ankylosing spondylitis	0.00158	0.00158	CcSEcCtD
Anagrelide—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.00158	0.00158	CcSEcCtD
Anagrelide—Hypertension—Prednisone—ankylosing spondylitis	0.00158	0.00158	CcSEcCtD
Anagrelide—Chills—Methotrexate—ankylosing spondylitis	0.00157	0.00157	CcSEcCtD
Anagrelide—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.00156	0.00156	CcSEcCtD
Anagrelide—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.00156	0.00156	CcSEcCtD
Anagrelide—Arthralgia—Prednisone—ankylosing spondylitis	0.00155	0.00155	CcSEcCtD
Anagrelide—Myalgia—Prednisone—ankylosing spondylitis	0.00155	0.00155	CcSEcCtD
Anagrelide—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.00155	0.00155	CcSEcCtD
Anagrelide—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.00155	0.00155	CcSEcCtD
Anagrelide—Alopecia—Methotrexate—ankylosing spondylitis	0.00155	0.00155	CcSEcCtD
Anagrelide—Insomnia—Betamethasone—ankylosing spondylitis	0.00155	0.00155	CcSEcCtD
Anagrelide—Insomnia—Dexamethasone—ankylosing spondylitis	0.00155	0.00155	CcSEcCtD
Anagrelide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.00154	0.00154	CcSEcCtD
Anagrelide—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.00154	0.00154	CcSEcCtD
Anagrelide—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.00154	0.00154	CcSEcCtD
Anagrelide—Paraesthesia—Betamethasone—ankylosing spondylitis	0.00154	0.00154	CcSEcCtD
Anagrelide—Discomfort—Prednisone—ankylosing spondylitis	0.00154	0.00154	CcSEcCtD
Anagrelide—Malnutrition—Methotrexate—ankylosing spondylitis	0.00153	0.00153	CcSEcCtD
Anagrelide—Dyspepsia—Betamethasone—ankylosing spondylitis	0.00151	0.00151	CcSEcCtD
Anagrelide—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.00151	0.00151	CcSEcCtD
Anagrelide—Urticaria—Triamcinolone—ankylosing spondylitis	0.0015	0.0015	CcSEcCtD
Anagrelide—Urticaria—Methylprednisolone—ankylosing spondylitis	0.00149	0.00149	CcSEcCtD
Anagrelide—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.00149	0.00149	CcSEcCtD
Anagrelide—Oedema—Prednisone—ankylosing spondylitis	0.00149	0.00149	CcSEcCtD
Anagrelide—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.00149	0.00149	CcSEcCtD
Anagrelide—Decreased appetite—Betamethasone—ankylosing spondylitis	0.00149	0.00149	CcSEcCtD
Anagrelide—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.00149	0.00149	CcSEcCtD
Anagrelide—Infection—Prednisone—ankylosing spondylitis	0.00148	0.00148	CcSEcCtD
Anagrelide—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.00148	0.00148	CcSEcCtD
Anagrelide—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.00148	0.00148	CcSEcCtD
Anagrelide—Back pain—Methotrexate—ankylosing spondylitis	0.00148	0.00148	CcSEcCtD
Anagrelide—Fatigue—Betamethasone—ankylosing spondylitis	0.00147	0.00147	CcSEcCtD
Anagrelide—Fatigue—Dexamethasone—ankylosing spondylitis	0.00147	0.00147	CcSEcCtD
Anagrelide—Shock—Prednisone—ankylosing spondylitis	0.00147	0.00147	CcSEcCtD
Anagrelide—Pain—Betamethasone—ankylosing spondylitis	0.00146	0.00146	CcSEcCtD
Anagrelide—Pain—Dexamethasone—ankylosing spondylitis	0.00146	0.00146	CcSEcCtD
Anagrelide—Nervous system disorder—Prednisone—ankylosing spondylitis	0.00146	0.00146	CcSEcCtD
Anagrelide—Tachycardia—Prednisone—ankylosing spondylitis	0.00145	0.00145	CcSEcCtD
Anagrelide—Skin disorder—Prednisone—ankylosing spondylitis	0.00145	0.00145	CcSEcCtD
Anagrelide—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.00144	0.00144	CcSEcCtD
Anagrelide—Vision blurred—Methotrexate—ankylosing spondylitis	0.00144	0.00144	CcSEcCtD
Anagrelide—Anorexia—Prednisone—ankylosing spondylitis	0.00142	0.00142	CcSEcCtD
Anagrelide—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.00142	0.00142	CcSEcCtD
Anagrelide—Anaemia—Methotrexate—ankylosing spondylitis	0.00141	0.00141	CcSEcCtD
Anagrelide—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.00141	0.00141	CcSEcCtD
Anagrelide—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.00141	0.00141	CcSEcCtD
Anagrelide—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.0014	0.0014	CcSEcCtD
Anagrelide—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.0014	0.0014	CcSEcCtD
Anagrelide—Malaise—Methotrexate—ankylosing spondylitis	0.00138	0.00138	CcSEcCtD
Anagrelide—Urticaria—Dexamethasone—ankylosing spondylitis	0.00136	0.00136	CcSEcCtD
Anagrelide—Urticaria—Betamethasone—ankylosing spondylitis	0.00136	0.00136	CcSEcCtD
Anagrelide—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.00136	0.00136	CcSEcCtD
Anagrelide—Dizziness—Prednisolone—ankylosing spondylitis	0.00136	0.00136	CcSEcCtD
Anagrelide—Asthenia—Triamcinolone—ankylosing spondylitis	0.00135	0.00135	CcSEcCtD
Anagrelide—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.00135	0.00135	CcSEcCtD
Anagrelide—Body temperature increased—Betamethasone—ankylosing spondylitis	0.00135	0.00135	CcSEcCtD
Anagrelide—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.00135	0.00135	CcSEcCtD
Anagrelide—Abdominal pain—Betamethasone—ankylosing spondylitis	0.00135	0.00135	CcSEcCtD
Anagrelide—Asthenia—Methylprednisolone—ankylosing spondylitis	0.00135	0.00135	CcSEcCtD
Anagrelide—Insomnia—Prednisone—ankylosing spondylitis	0.00135	0.00135	CcSEcCtD
Anagrelide—Paraesthesia—Prednisone—ankylosing spondylitis	0.00134	0.00134	CcSEcCtD
Anagrelide—Pruritus—Triamcinolone—ankylosing spondylitis	0.00133	0.00133	CcSEcCtD
Anagrelide—Cough—Methotrexate—ankylosing spondylitis	0.00133	0.00133	CcSEcCtD
Anagrelide—Pruritus—Methylprednisolone—ankylosing spondylitis	0.00133	0.00133	CcSEcCtD
Anagrelide—Convulsion—Methotrexate—ankylosing spondylitis	0.00132	0.00132	CcSEcCtD
Anagrelide—Dyspepsia—Prednisone—ankylosing spondylitis	0.00131	0.00131	CcSEcCtD
Anagrelide—Arthralgia—Methotrexate—ankylosing spondylitis	0.0013	0.0013	CcSEcCtD
Anagrelide—Chest pain—Methotrexate—ankylosing spondylitis	0.0013	0.0013	CcSEcCtD
Anagrelide—Myalgia—Methotrexate—ankylosing spondylitis	0.0013	0.0013	CcSEcCtD
Anagrelide—Decreased appetite—Prednisone—ankylosing spondylitis	0.00129	0.00129	CcSEcCtD
Anagrelide—Rash—Prednisolone—ankylosing spondylitis	0.00129	0.00129	CcSEcCtD
Anagrelide—Dermatitis—Prednisolone—ankylosing spondylitis	0.00129	0.00129	CcSEcCtD
Anagrelide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.00129	0.00129	CcSEcCtD
Anagrelide—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00129	0.00129	CcSEcCtD
Anagrelide—Fatigue—Prednisone—ankylosing spondylitis	0.00128	0.00128	CcSEcCtD
Anagrelide—Headache—Prednisolone—ankylosing spondylitis	0.00128	0.00128	CcSEcCtD
Anagrelide—Discomfort—Methotrexate—ankylosing spondylitis	0.00128	0.00128	CcSEcCtD
Anagrelide—Constipation—Prednisone—ankylosing spondylitis	0.00127	0.00127	CcSEcCtD
Anagrelide—Confusional state—Methotrexate—ankylosing spondylitis	0.00126	0.00126	CcSEcCtD
Anagrelide—Dizziness—Triamcinolone—ankylosing spondylitis	0.00125	0.00125	CcSEcCtD
Anagrelide—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00124	0.00124	CcSEcCtD
Anagrelide—Infection—Methotrexate—ankylosing spondylitis	0.00124	0.00124	CcSEcCtD
Anagrelide—Feeling abnormal—Prednisone—ankylosing spondylitis	0.00123	0.00123	CcSEcCtD
Anagrelide—Asthenia—Betamethasone—ankylosing spondylitis	0.00123	0.00123	CcSEcCtD
Anagrelide—Asthenia—Dexamethasone—ankylosing spondylitis	0.00123	0.00123	CcSEcCtD
Anagrelide—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.00122	0.00122	CcSEcCtD
Anagrelide—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.00122	0.00122	CcSEcCtD
Anagrelide—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.00122	0.00122	CcSEcCtD
Anagrelide—Nausea—Prednisolone—ankylosing spondylitis	0.00122	0.00122	CcSEcCtD
Anagrelide—Pruritus—Betamethasone—ankylosing spondylitis	0.00121	0.00121	CcSEcCtD
Anagrelide—Pruritus—Dexamethasone—ankylosing spondylitis	0.00121	0.00121	CcSEcCtD
Anagrelide—Skin disorder—Methotrexate—ankylosing spondylitis	0.00121	0.00121	CcSEcCtD
Anagrelide—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.0012	0.0012	CcSEcCtD
Anagrelide—Vomiting—Triamcinolone—ankylosing spondylitis	0.0012	0.0012	CcSEcCtD
Anagrelide—Vomiting—Methylprednisolone—ankylosing spondylitis	0.0012	0.0012	CcSEcCtD
Anagrelide—Rash—Triamcinolone—ankylosing spondylitis	0.00119	0.00119	CcSEcCtD
Anagrelide—Dermatitis—Triamcinolone—ankylosing spondylitis	0.00119	0.00119	CcSEcCtD
Anagrelide—Anorexia—Methotrexate—ankylosing spondylitis	0.00119	0.00119	CcSEcCtD
Anagrelide—Rash—Methylprednisolone—ankylosing spondylitis	0.00119	0.00119	CcSEcCtD
Anagrelide—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.00118	0.00118	CcSEcCtD
Anagrelide—Urticaria—Prednisone—ankylosing spondylitis	0.00118	0.00118	CcSEcCtD
Anagrelide—Headache—Triamcinolone—ankylosing spondylitis	0.00118	0.00118	CcSEcCtD
Anagrelide—Headache—Methylprednisolone—ankylosing spondylitis	0.00118	0.00118	CcSEcCtD
Anagrelide—Abdominal pain—Prednisone—ankylosing spondylitis	0.00118	0.00118	CcSEcCtD
Anagrelide—Body temperature increased—Prednisone—ankylosing spondylitis	0.00118	0.00118	CcSEcCtD
Anagrelide—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.00117	0.00117	CcSEcCtD
Anagrelide—Diarrhoea—Betamethasone—ankylosing spondylitis	0.00117	0.00117	CcSEcCtD
Anagrelide—Hypotension—Methotrexate—ankylosing spondylitis	0.00116	0.00116	CcSEcCtD
Anagrelide—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.00113	0.00113	CcSEcCtD
Anagrelide—Dizziness—Betamethasone—ankylosing spondylitis	0.00113	0.00113	CcSEcCtD
Anagrelide—Dizziness—Dexamethasone—ankylosing spondylitis	0.00113	0.00113	CcSEcCtD
Anagrelide—Insomnia—Methotrexate—ankylosing spondylitis	0.00113	0.00113	CcSEcCtD
Anagrelide—Nausea—Triamcinolone—ankylosing spondylitis	0.00112	0.00112	CcSEcCtD
Anagrelide—Paraesthesia—Methotrexate—ankylosing spondylitis	0.00112	0.00112	CcSEcCtD
Anagrelide—Nausea—Methylprednisolone—ankylosing spondylitis	0.00112	0.00112	CcSEcCtD
Anagrelide—Dyspnoea—Methotrexate—ankylosing spondylitis	0.00111	0.00111	CcSEcCtD
Anagrelide—Somnolence—Methotrexate—ankylosing spondylitis	0.00111	0.00111	CcSEcCtD
Anagrelide—Dyspepsia—Methotrexate—ankylosing spondylitis	0.0011	0.0011	CcSEcCtD
Anagrelide—Vomiting—Betamethasone—ankylosing spondylitis	0.00109	0.00109	CcSEcCtD
Anagrelide—Vomiting—Dexamethasone—ankylosing spondylitis	0.00109	0.00109	CcSEcCtD
Anagrelide—Decreased appetite—Methotrexate—ankylosing spondylitis	0.00108	0.00108	CcSEcCtD
Anagrelide—Rash—Betamethasone—ankylosing spondylitis	0.00108	0.00108	CcSEcCtD
Anagrelide—Rash—Dexamethasone—ankylosing spondylitis	0.00108	0.00108	CcSEcCtD
Anagrelide—Dermatitis—Dexamethasone—ankylosing spondylitis	0.00108	0.00108	CcSEcCtD
Anagrelide—Dermatitis—Betamethasone—ankylosing spondylitis	0.00108	0.00108	CcSEcCtD
Anagrelide—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.00107	0.00107	CcSEcCtD
Anagrelide—Fatigue—Methotrexate—ankylosing spondylitis	0.00107	0.00107	CcSEcCtD
Anagrelide—Headache—Betamethasone—ankylosing spondylitis	0.00107	0.00107	CcSEcCtD
Anagrelide—Headache—Dexamethasone—ankylosing spondylitis	0.00107	0.00107	CcSEcCtD
Anagrelide—Asthenia—Prednisone—ankylosing spondylitis	0.00107	0.00107	CcSEcCtD
Anagrelide—Pain—Methotrexate—ankylosing spondylitis	0.00106	0.00106	CcSEcCtD
Anagrelide—Pruritus—Prednisone—ankylosing spondylitis	0.00105	0.00105	CcSEcCtD
Anagrelide—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.00103	0.00103	CcSEcCtD
Anagrelide—Diarrhoea—Prednisone—ankylosing spondylitis	0.00102	0.00102	CcSEcCtD
Anagrelide—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.00102	0.00102	CcSEcCtD
Anagrelide—Nausea—Dexamethasone—ankylosing spondylitis	0.00102	0.00102	CcSEcCtD
Anagrelide—Nausea—Betamethasone—ankylosing spondylitis	0.00102	0.00102	CcSEcCtD
Anagrelide—Urticaria—Methotrexate—ankylosing spondylitis	0.000989	0.000989	CcSEcCtD
Anagrelide—Dizziness—Prednisone—ankylosing spondylitis	0.000985	0.000985	CcSEcCtD
Anagrelide—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000984	0.000984	CcSEcCtD
Anagrelide—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000984	0.000984	CcSEcCtD
Anagrelide—Vomiting—Prednisone—ankylosing spondylitis	0.000947	0.000947	CcSEcCtD
Anagrelide—Rash—Prednisone—ankylosing spondylitis	0.000939	0.000939	CcSEcCtD
Anagrelide—Dermatitis—Prednisone—ankylosing spondylitis	0.000938	0.000938	CcSEcCtD
Anagrelide—Headache—Prednisone—ankylosing spondylitis	0.000933	0.000933	CcSEcCtD
Anagrelide—Asthenia—Methotrexate—ankylosing spondylitis	0.000893	0.000893	CcSEcCtD
Anagrelide—Nausea—Prednisone—ankylosing spondylitis	0.000885	0.000885	CcSEcCtD
Anagrelide—Pruritus—Methotrexate—ankylosing spondylitis	0.000881	0.000881	CcSEcCtD
Anagrelide—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000852	0.000852	CcSEcCtD
Anagrelide—Dizziness—Methotrexate—ankylosing spondylitis	0.000823	0.000823	CcSEcCtD
Anagrelide—Vomiting—Methotrexate—ankylosing spondylitis	0.000791	0.000791	CcSEcCtD
Anagrelide—Rash—Methotrexate—ankylosing spondylitis	0.000785	0.000785	CcSEcCtD
Anagrelide—Dermatitis—Methotrexate—ankylosing spondylitis	0.000784	0.000784	CcSEcCtD
Anagrelide—Headache—Methotrexate—ankylosing spondylitis	0.00078	0.00078	CcSEcCtD
Anagrelide—Nausea—Methotrexate—ankylosing spondylitis	0.000739	0.000739	CcSEcCtD
